Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent P...

FDA Drug Recall #D-0768-2022 — Class II — March 23, 2022

Recall Summary

Recall Number D-0768-2022
Classification Class II — Moderate risk
Date Initiated March 23, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Preferred Pharmaceuticals, Inc.
Location Anaheim, CA
Product Type Drugs
Quantity 1568 bottles

Product Description

Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED Pharmaceuticals, Inc., The Physician's Solution, NDC 68788-7768-01

Reason for Recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.

Distribution Pattern

IL

Lot / Code Information

Lot #: A0721O, A1421Y, A2121G, A2821D, B0421H, B0421I, B0521U, B1121G, B1921C, C0421B, C1821N, L0120F, L2320O, L3020T, Exp.: 4/30/2022; B2521A, C1121S, C2521U, D0121S, D0921B, D1421B, D2921C, E0721A, Exp.: 10/31/2022; D2221A, Exp.: 12/31/2022

Other Recalls from Preferred Pharmaceuticals, Inc.

Recall # Classification Product Date
D-0239-2026 Class II Ondansetron ODT Tablets, USP 4mg, 1x10 unit do... Nov 17, 2025
D-0391-2025 Class II Clindamycin Hydrochloride Capsules, USP, 300mg,... Apr 18, 2025
D-0647-2024 Class II Ibuprofen Tablets, USP 400mg, Generic for Motri... Aug 8, 2024
D-0505-2024 Class II Duloxetine Delayed-Release Cap USP 30mg, 30-cou... May 10, 2024
D-0894-2023 Class II Tizanidine Hydrochloride Tablet 4mg, packaged i... Jun 26, 2023

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.